Area of research
Cancer Research · Genetics
Research interest
Research interests include Medicine, Cancer research, Biology, Paraganglioma, Carcinogenesis, and Germline mutation.
H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia
DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling
Small posterior fossa in Chiari I malformation affected families is significantly linked to 1q43-44 and 12q23-24.11 using whole exome sequencing
Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade
Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma
Recurrent somatic mutations of <i>PRKAR1A</i> in isolated cardiac myxoma
Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
Hypotaurine evokes a malignant phenotype in glioma through aberrant hypoxic signaling
Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster
Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy
CHCHD2 gene mutations in familial and sporadic Parkinson's disease
Somatic mosaicism of EPAS1 mutations in the syndrome of paraganglioma and somatostatinoma associated with polycythemia
Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas
Somatic<i>HIF2A</i>Gain-of-Function Mutations in Paraganglioma with Polycythemia
A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma
Neuronatin in a Subset of Glioblastoma Multiforme Tumor Progenitor Cells Is Associated with Increased Cell Proliferation and Shorter Patient Survival